1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) and related derivatives:: Chemistry and biochemical effects on catecholamine biosynthesis

被引:18
|
作者
Bringmann, G [1 ]
Feineis, D
God, R
Peters, K
Peters, EM
Scholz, J
Riederer, F
Moser, A
机构
[1] Univ Wurzburg, Inst Organ Chem, D-97074 Wurzburg, Germany
[2] Max Planck Inst Festkorperforsch, D-70506 Stuttgart, Germany
[3] Univ Klinikum Lubeck, Neurol Klin, D-23538 Lubeck, Germany
关键词
D O I
10.1016/S0968-0896(02)00060-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1-Trichloromethyl-1.2.3.4-tetrahydro-beta-carboline (TaClo, 2) is a mammalian alkaloid that readily originates in the human organism, by Pictet-Spengler condensation of endogenously present tryptamine (Ta) and the non-natural hypnotic agent trichloroacetaldehyde (chloral. Clo). Due to its structural analogy to the neurotoxin 1-methyl-4-phenyl-1.2.3.6-tetrahydropyridine (MPTP. 1). TaClo is discussed to possibly contribute to the pathogenesis of Parkinson's disease acting as an environmental toxin. Previous investigations on rats and neuronal cell cultures repealed 2 to be capable of inducing severe disturbances on the dopamine metabolism. In this paper, c report on the effects of 2 on the activity of tyrosine hydroxylase [L-tyrosine. tetrahydropteridine oxygen oxidoreductase (3-hydroxylating). EC 1.14,6.2: TH] in vitro using rat brain homogenates prepared from the TH-rich nucleus accumbens. TaClo (2) dose-dependently inhibited basal TH activity (IC50 = 3 muM), and after enzyme activation by pituitary adenylate cyclase-activating polypeptide (PACAP-27), it also reduced L-DOPA formation (IC50 = 15 muM). Moreover, two presumable denylate TaClo metabolites, 2-methyl-TaClo (N-Me-TaClo, 3) and 1-dichloromethylene-1,2.3.4-tetrahydro-beta-carboline (1-CCl2-THbetaC. 4). which were synthesized in good yields, also proved to be potent inhibitors of TH, with the strongest effect on basal activity (similar to TaClo) being obscerved for 3 (IC50 = 3 muM). In contrast to TaClo, however, 3 and 4 showed biphasic effects after TH activation with PACAP-27, inducing a marked increase of enzyme activity in the nanomolar range ( <0.1 μM), awhile TH activity was nearly completely blocked at high concentrations (IC100 = 0.1 mM). An X-ray diffraction investigation on the 3-dimensional structure of the 1-CCl2-THβC-derived trifluoroacetamide 7 revealed the voluminous and quite rigid dichloromethylene substituent to be only moderately twisted out of the β-carboline ring 'plane'. thus resulting in an inreased ring strain of the partially hydrogenated pyrido moiety accompanied by a strong steric hindrance of Cl(1), Cl(2) C(13), and N(2), which pushes the N-trifluoroacetyl group upwards to an even higher extent than for the TaClo-related trifluoroacetamide 8. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2207 / 2214
页数:8
相关论文
共 50 条
  • [1] Effect of 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) on human serotonergic cells
    Bringmann, G
    Brückner, R
    Mössner, R
    Feineis, D
    Heils, A
    Lesch, KP
    NEUROCHEMICAL RESEARCH, 2000, 25 (06) : 837 - 843
  • [2] Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives
    Grote, C
    Clement, HW
    Wesemann, W
    Bringmann, G
    Feineis, D
    Riederer, P
    Sontag, KH
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1995, (46): : 275 - 281
  • [3] 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) induces apoptosis in human neuroblastoma cell lines
    Akundi, RS
    Hüll, M
    Clement, HW
    Fiebich, BL
    APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS, 2003, 1010 : 304 - 306
  • [4] The long-term effects of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) on cognitive performance in rats
    Sontag, T. A.
    Lange, K. W.
    Heim, Ch.
    Kolasiewicz, W.
    Tucha, O.
    Sontag, K.-H.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2007, (72): : 149 - 154
  • [5] Basic studies on epigenetic carcinogenesis of low-dose exposure to 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in vitro
    Wang, Renjie
    Cui, Yi
    Xu, Yi
    Irudayaraj, Joseph
    PLOS ONE, 2017, 12 (02):
  • [6] The TaClo concept: 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons
    Bringmann, G
    God, R
    Feineis, D
    Wesemann, W
    Riederer, P
    Rausch, WD
    Reichmann, H
    Sontag, KH
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1995, (46): : 235 - 244
  • [7] Toxicity and metabolism of the chloral-derived mammalian alkaloid 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in PC12 cells
    Bringmann, Gerhard
    Feineis, Doris
    Muenchbach, Miriam
    God, Ralf
    Peters, Karl
    Peters, Eva-Maria
    Moessner, Rainald
    Lesch, Klaus-Peter
    ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 2006, 61 (7-8): : 601 - 610
  • [8] Synthesis of radiolabelled 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo), a neurotoxic chloral-derived mammalian alkaloid, and its biodistribution in rats
    Bringmann, Gerhard
    Feineis, Doris
    Brueckner, Ralph
    God, Ralf
    Grote, Christoph
    Wesemann, Wolfgang
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 (05) : 412 - 422
  • [9] 1-TRICHLOROMETHYL-1,2,3,4-TETRAHYDRO-BETA-CARBOLINE, TACLO - A NEW TOXIN FOR CENTRAL-NERVOUS-SYSTEM
    BRINGMANN, G
    REICHMANN, H
    SONTAG, KH
    WESEMANN, W
    RIEDERER, P
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S66 - S66
  • [10] Studies on single-strand scissions to cell-free plasmid DNA by the dopaminergic neurotoxin 'TaClo' (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline)
    Bringmann, G
    Münchbach, M
    Feineis, D
    Faulhaber, K
    Ihmels, H
    NEUROSCIENCE LETTERS, 2001, 304 (1-2) : 41 - 44